Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
Treatment of chronic progressive multiple sclerosis with intravenous immunoglobulins--interim results on drug safety of an ongoing study. IVIG study groupD PoehlauAnnals of Hematology|November 1, 1994
Is alpha-methyldopa-type autoimmune hemolytic anemia mediated by interferon-gamma?J E Baier, D PoehlauJournal of Neurology, Neurosurgery, and Psychiatry|August 1, 1991
Neurophysiological findings and MRI in anterior spinal artery syndrome of the lower cervical cord: the value of F-wavesG Amoiridis, D Poehlau, H PrzuntekReviews in the Neurosciences|January 1, 1997
The neuroimmune hypothesis in Parkinson's diseaseW Kuhn, T Müller, I Nastos, et al.Vox Sanguinis|April 15, 2000
Therapeutic immunoadsorption increases the level of circulating soluble HLA moleculesD Poehlau, U Kiltz, M Rieks, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 1997
Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trialD Poehlau, J Federlein, T Postert, et al.Fortschritte Der Medizin|November 10, 1996
[Mechanisms of action of intravenous immunoglobulins]D Poehlau, T Postert, M Rieks, et al.Fortschritte Der Medizin|April 30, 1994
[Is dopaminergic therapy immunologically rejuvinating? Increased interferon-gamma production with the dopaminergic agent lisuride]D Poehlau, J E Baier, S Kovacs, et al.Plos One|September 23, 2015
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic ReviewT Ziemssen, S Rauer, C Stadelmann, et al.Annals of Neurology|March 1, 1997
Genetic predisposition to multiple sclerosis as revealed by immunoprintingC Epplen, S Jäckel, E J Santos, et al.Pageof 2